Clinical Trials Directory

Trials / Completed

CompletedNCT05487209

Clinical Value of the MRI Combined With SCC-Ag for the Diagnosis of HSIL (CIN 2/3)

Clinical Value of the MRI Combined With SCC-Ag for the Diagnosis of High-grade Cervical Squamous Neoplasia (Cervical Intra-epithelial Neoplasia Grades 2 and 3 (CIN 2/3))

Status
Completed
Phase
Study type
Observational
Enrollment
186 (actual)
Sponsor
Second Affiliated Hospital of Wenzhou Medical University · Academic / Other
Sex
Female
Age
26 Years – 82 Years
Healthy volunteers
Not accepted

Summary

The study aimed to identify the clinical value of Magnetic Resonance Imaging examination (MRI)combined with serum squamous cells carcinoma antigen (SCC-Ag) in women with high-grade squamous intraepithelial lesion (cervical intraepithelial neoplasia grades 2-3 (CIN 2-3)).

Detailed description

186 female patients with the HSIL(CIN2-3) were included in this study and followed up from the time of admission. All patients underwent colposcopy examination, MRI, SCC-Ag, loop electrosurgical excision procedure (LEEP), extrafascial hysterectomy, or radical hysterectomy. Pathological findings of the patient's tissues were used as the final diagnostic criteria. On the one hand, we compared the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of MRI+SCC-Ag, LEEP of the menopausal group, and non-menopausal group. On the other hand, evaluating the accuracy of MRI combined with SCC-Ag examination in diagnosing HSIL(CIN2-3) by receiver-operating characteristic curve (ROC).

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMRI,SCC-AgMagnetic Resonance Imaging examination,serum squamous cells carcinoma antigen

Timeline

Start date
2021-03-01
Primary completion
2022-12-01
Completion
2022-12-31
First posted
2022-08-04
Last updated
2023-07-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05487209. Inclusion in this directory is not an endorsement.